Union Health Minister discusses roadmap for Indian pharma sector Ruchika Sharma4 July 2022 11:36 AM ISTReiterating the Prime Minister's vision of attaining Aatmanirbharta in all fields, Mandaviya pushed for making the pharmaceutical sector leapfrog in...
Merck launches Merck Digital Sciences Studio for healthcare startups Ruchika Sharma3 July 2022 4:00 PM ISTCurrently the program plans to include six startups at each of the Newark, NJ and Cambridge, MA venues.
Novartis leaning toward spinoff of USD 25 billion generics arm: Bloomberg Ruchika Sharma3 July 2022 12:30 PM ISTNew Delhi: Novartis AG is leaning toward a spinoff of its generic-drug unit, as a challenging environment for leveraged buyouts makes a potential sale...
Novavax likely to come up with COVID vaccine targeting Omicron in Q4 Ruchika Sharma3 July 2022 12:30 PM ISTNew Delhi: Novavax Inc said on Friday it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development...
Oxford Biomedica signs new deal to make AstraZeneca COVID vaccine Ruchika Sharma3 July 2022 12:00 PM ISTOxford: Oxford Biomedica plc, a gene and cell therapy group, has announced that it has signed a new three year Master Services & Development...
Thyrocare launches new Regional Processing Lab in Raipur Ruchika Sharma3 July 2022 9:30 AM ISTThe laboratory will cater to testing needs of patients, doctors, diagnostics centers, hospitals, nursing homes and other healthcare facilities in...
Glenmark gets one USFDA observation for Aurangabad facility Ruchika Sharma2 July 2022 4:29 PM ISTNew Delhi: Glenmark Pharmaceuticals Limited has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with...
USFDA recommends COVID booster targeting Omicron subvariants Ruchika Sharma2 July 2022 1:45 PM ISTThe Omicron BA.4 and BA.5 variants, currently driving the fresh wave of Covid cases globally, are known to evade vaccine induced immunity.
USFDA places clinical hold on Phase 3 Tolebrutinib studies: Sanofi Ruchika Sharma2 July 2022 12:45 PM ISTThe FDA action was based on a limited number of cases of drug-induced liver injury that have been identified with tolebrutinib exposure in Phase 3...
Pfizer seeks USFDA nod for COVID drug Paxlovid for high-risk patients Ruchika Sharma2 July 2022 11:55 AM ISTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
PharmEasy deploys Unicommerce integrated SaaS platform for its marketplace operations Ruchika Sharma2 July 2022 10:00 AM ISTNew Delhi: PharmEasy, India's consumer healthcare 'super app' (providing online pharmacy, OTC, teleconsultation and diagnostics services), has...
MediSim VR sets up fully automated Virtual Reality lab in Puducherry Institute of Medical Sciences for MBBS students Ruchika Sharma1 July 2022 4:03 PM ISTWith the Indian Medical Industry waking up to virtual reality, doctors, surgeons, medical practitioners, drug makers, and hospitals are increasingly...
